APOE Alleles and Diet in Brain Aging and Alzheimer’s Disease

Abondio, 2019, The genetic variability of APOE in different human populations and its implications for longevity, Genes, 10, E222, 10.3390/genes10030222

Adeosun, 2019, Female mice with apolipoprotein E4 domain interaction demonstrated impairments in spatial learning and memory performance and disruption of hippocampal cyto-architecture, Neurobiol. Learn. Mem., 161, 106, 10.1016/j.nlm.2019.03.012

Altenburg, 2008, Human LDL receptor enhances sequestration of ApoE4 and VLDL remnants on the surface of hepatocytes but not their internalization in mice, Arterioscler. Thromb. Vasc. Biol., 28, 1104, 10.1161/atvbaha.108.164863

Andrieu, 2017, Effect of long-term omega 3 polyunsaturated fatty acid supplementation with or without multidomain intervention on cognitive function in elderly adults with memory complaints (MAPT): a randomised, placebo-controlled trial, Lancet Neurol., 16, 377, 10.1016/S1474-4422(17)30040-6

Arbones-Mainar, 2010, Impaired adipogenic response to thiazolidinediones in mice expressing human apolipoproteinE4, FASEB J., 24, 3809, 10.1096/fj.10-159517

Arbones-Mainar, 2008, Differential modulation of diet-induced obesity and adipocyte functionality by human apolipoprotein E3 and E4 in mice, Int. J. Obes., 32, 1595, 10.1038/ijo.2008.143

Arbones-Mainar, 2016, Metabolic shifts toward fatty-acid usage and increased thermogenesis are associated with impaired adipogenesis in mice expressing human APOE4, Int. J. Obes., 40, 1574, 10.1038/ijo.2016.93

Azevedo, 2014, Apolipoprotein E plays a key role against cryptosporidial infection in transgenic undernourished mice, PLoS One, 9, e89562, 10.1371/journal.pone.0089562

Babulal, 2019, Perspectives on ethnic and racial disparities in Alzheimer’s disease and related dementias: update and areas of immediate need, Alzheimers Dement., 15, 292, 10.1016/j.jalz.2018.09.009

Backman, 2015, 37 years of body mass index and dementia: effect modification by the apoe genotype: observations from the prospective population study of women in Gothenburg, Sweden, J. Alzheimers Dis., 48, 1119, 10.3233/jad-150326

Baitsch, 2011, Apolipoprotein E induces antiinflammatory phenotype in macrophages, Arterioscler. Thromb. Vasc. Biol., 31, 1160, 10.1161/ATVBAHA.111.222745

Barberger-Gateau, 2007, Dietary patterns and risk of dementia: the three-city cohort study, Neurology, 69, 1921, 10.1212/01.wnl.0000278116.37320.52

Bell, 2012, Apolipoprotein E controls cerebrovascular integrity via cyclophilin A, Nature, 485, 512, 10.1038/nature11087

Beydoun, 2007, Plasma n-3 fatty acids and the risk of cognitive decline in older adults: the atherosclerosis risk in communities study, Am. J. Clin. Nutr., 85, 1103, 10.1093/ajcn/85.4.1103

Blanchard, 2018, Kinetics of plasma apolipoprotein E isoforms by LC-MS/MS: a pilot study, J. Lipid Res., 59, 892, 10.1194/jlr.P083576

Blum, 1982, Dynamics of apolipoprotein E metabolism in humans, J. Lipid Res., 23, 1308, 10.1016/S0022-2275(20)38036-6

Boros, 2019, Dendritic spine remodeling accompanies Alzheimer’s disease pathology and genetic susceptibility in cognitively normal aging, Neurobiol. Aging, 73, 92, 10.1016/j.neurobiolaging.2018.09.003

Braun, 2006, Intracellular trafficking of recycling apolipoprotein E in Chinese hamster ovary cells, J. Lipid Res., 47, 1176, 10.1194/jlr.m500503-jlr200

Brifault, 2017, Shedding of membrane-associated LDL receptor-related protein-1 from microglia amplifies and sustains neuroinflammation, J. Biol. Chem., 292, 18699, 10.1074/jbc.m117.798413

Burns, 2019, The TOMMORROW study: Design of an Alzheimer’s disease delay-of-onset clinical trial, Alzheimers Dement. (N Y), 5, 661, 10.1016/j.trci.2019.09.010

Carvalho-Wells, 2012, APOE genotype influences triglyceride and C-reactive protein responses to altered dietary fat intake in UK adults, Am. J. Clin. Nutr., 96, 1447, 10.3945/ajcn.112.043240

Cataldo, 2000, Endocytic pathway abnormalities precede amyloid β deposition in sporadic Alzheimer’s disease and Down syndrome: differential effects of APOE genotype and presenilin mutations, Am. J. Pathol., 157, 277, 10.1016/s0002-9440(10)64538-5

Chang, 2016, Gray matter maturation and cognition in children with different APOE epsilon genotypes, Neurology, 87, 585, 10.1212/wnl.0000000000002939

Chawla, 2001, A PPARγ-LXR-ABCA1 pathway in macrophages is involved in cholesterol efflux and atherogenesis, Mol. Cell, 7, 161, 10.1016/s1097-2765(01)00164-2

Chen, 2010, ApoE4 reduces glutamate receptor function and synaptic plasticity by selectively impairing ApoE receptor recycling, Proc. Natl. Acad. Sci. U S A, 107, 12011, 10.1073/pnas.0914984107

Chetty, 2017, Helical structure, stability and dynamics in human apolipoprotein E3 and E4 by hydrogen exchange and mass spectrometry, Proc. Natl. Acad. Sci. U S A, 114, 968, 10.1073/pnas.1617523114

Conway, 2014, Apolipoprotein E isoforms disrupt long-chain fatty acid distribution in the plasma, the liver and the adipose tissue of mice, Prostaglandins Leukot. Essent. Fatty Acids, 91, 261, 10.1016/j.plefa.2014.09.007

Cui, 2011, Activation of liver X receptor decreases BACE1 expression and activity by reducing membrane cholesterol levels, Neurochem. Res., 36, 1910, 10.1007/s11064-011-0513-3

Cummings, 2016, Double-blind, placebo-controlled, proof-of-concept trial of bexarotene in moderate Alzheimer’s disease, Alzheimers Res. Ther., 8, 4, 10.1186/s13195-016-0173-2

Daiello, 2015, Association of fish oil supplement use with preservation of brain volume and cognitive function, Alzheimers Dement., 11, 226, 10.1016/j.jalz.2014.02.005

Dallongeville, 1992, Modulation of plasma triglyceride levels by apoE phenotype: a meta-analysis, J. Lipid Res., 33, 447, 10.1016/S0022-2275(20)41611-6

Di Cerbo, 2016, Mechanisms and therapeutic effectiveness of lactobacilli, J. Clin. Pathol., 69, 187, 10.1136/jclinpath-2015-202976

Dong, 1996, Human apolipoprotein E4 domain interaction. Arginine 61 and glutamic acid 255 interact to direct the preference for very low density lipoproteins, J. Biol. Chem., 271, 19053, 10.1074/jbc.271.32.19053

Elosua, 2003, Obesity modulates the association among APOE genotype, insulin and glucose in men, Obes. Res., 11, 1502, 10.1038/oby.2003.201

Espeland, 2017, Effect of a long-term intensive lifestyle intervention on prevalence of cognitive impairment, Neurology, 88, 2026, 10.1212/WNL.0000000000003955

Fallaize, 2017, APOE genotype influences insulin resistance, apolipoprotein CII and CIII according to plasma fatty acid profile in the Metabolic Syndrome, Sci. Rep., 7, 6274, 10.1038/s41598-017-05802-2

Fan, 2011, An ABCA1-independent pathway for recycling a poorly lipidated 8.1 nm apolipoprotein E particle from glia, J. Lipid Res., 52, 1605, 10.1194/jlr.m014365

Farkas, 2003, The recycling of apolipoprotein E in primary cultures of mouse hepatocytes: evidence for a physiologic connection to high density lipoprotein metabolism, J. Biol. Chem., 278, 9412, 10.1074/jbc.m208026200

Farmer, 2019, Apolipoprotein E4 alters astrocyte fatty acid metabolism and lipid droplet formation, Cells, 8, E182, 10.3390/cells8020182

Farrer, 1997, Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease: a meta-analysis, JAMA, 278, 1349, 10.1001/jama.1997.03550160069041

Fernandez, 2019, The role of APOE4 in disrupting the homeostatic functions of astrocytes and microglia in aging and Alzheimer’s disease, Front. Aging Neurosci., 11, 14, 10.3389/fnagi.2019.00014

Finch, 2010, Evolution of the human lifespan and diseases of aging: roles of infection, inflammation and nutrition, Proc. Natl. Acad. Sci. U S A, 107, 1718, 10.1073/pnas.0909606106

Finch, 2016, Apolipoprotein E and sex bias in cerebrovascular aging of men and mice, Trends Neurosci., 39, 625, 10.1016/j.tins.2016.07.002

Finch, 2019, The Alzheimer’s disease exposome, Alzheimers Dement., 15, 1123, 10.1016/j.jalz.2019.06.3914

Flowers, 2020, O-glycosylation on cerebrospinal fluid and plasma apolipoprotein E differs in the lipid-binding domain, Glycobiology, 30, 74, 10.1093/glycob/cwz084

Gale, 2014, APOε4 is associated with enhanced in vivo innate immune responses in human subjects, J. Allergy Clin. Immunol., 134, 127.e9, 10.1016/j.jaci.2014.01.032

Ghebranious, 2011, A pilot study of gene/gene and gene/environment interactions in Alzheimer disease, Clin. Med. Res., 9, 17, 10.3121/cmr.2010.894

Gong, 2002, Apolipoprotein E (ApoE) isoform-dependent lipid release from astrocytes prepared from human ApoE3 and ApoE4 knock-in mice, J. Biol. Chem., 277, 29919, 10.1074/jbc.m203934200

Griffin, 2018, APOE4 genotype exerts greater benefit in lowering plasma cholesterol and apolipoprotein B than wild type (E3/E3), after replacement of dietary saturated fats with low glycaemic index carbohydrates, Nutrients, 10, E1524, 10.3390/nu10101524

Haan, 2003, Prevalence of dementia in older latinos: the influence of type 2 diabetes mellitus, stroke and genetic factors, J. Am. Geriatr. Soc., 51, 169, 10.1046/j.1532-5415.2003.51054.x

Halliday, 2013, Relationship between cyclophilin a levels and matrix metalloproteinase 9 activity in cerebrospinal fluid of cognitively normal apolipoprotein e4 carriers and blood-brain barrier breakdown, JAMA Neurol., 70, 1198, 10.1001/jamaneurol.2013.3841

Hamilton, 2015, Aberrant lipid metabolism in the forebrain niche suppresses adult neural stem cell proliferation in an animal model of Alzheimer’s disease, Cell Stem Cell, 17, 397, 10.1016/j.stem.2015.08.001

Hanson, 2015, Differential effects of meal challenges on cognition, metabolism and biomarkers for apolipoprotein E varepsilon4 carriers and adults with mild cognitive impairment, J. Alzheimers Dis., 48, 205, 10.3233/jad-150273

Heeren, 2003, Recycling of apoprotein E Is associated with cholesterol efflux and high density lipoprotein internalization, J. Biol. Chem., 278, 14370, 10.1074/jbc.m209006200

Heeren, 2004, Impaired recycling of apolipoprotein E4 is associated with intracellular cholesterol accumulation, J. Biol. Chem., 279, 55483, 10.1074/jbc.m409324200

Henderson, 2009, Study of the ketogenic agent AC-1202 in mild to moderate Alzheimer’s disease: a randomized, double-blind, placebo-controlled, multicenter trial, Nutr. Metab., 6, 31, 10.1186/1743-7075-6-31

Hu, , Simple and fast assay for apolipoprotein E phenotyping and glycotyping: discovering isoform-specific glycosylation in plasma and cerebrospinal fluid, J. Alzheimers Dis.

Huang, 2006, Distinct cellular loci for the ABCA1-dependent and ABCA1-independent lipid efflux mediated by endogenous apolipoprotein E expression, Arterioscler. Thromb. Vasc. Biol., 26, 157, 10.1161/01.atv.0000193627.12516.1d

Huang, 2005, Benefits of fatty fish on dementia risk are stronger for those without APOE epsilon4, Neurology, 65, 1409, 10.1212/01.wnl.0000183148.34197.2e

Hubin, 2019, Apolipoprotein E associated with reconstituted high-density lipoprotein-like particles is protected from aggregation, FEBS Lett., 593, 1144, 10.1002/1873-3468.13428

Jansen, 2015, Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis, JAMA, 313, 1924, 10.1001/jama.2015.4668

Ji, 2003, Apolipoprotein E isoform-specific regulation of dendritic spine morphology in apolipoprotein E transgenic mice and Alzheimer’s disease patients, Neuroscience, 122, 305, 10.1016/j.neuroscience.2003.08.007

Jofre-Monseny, 2007, Effects of apoE genotype on macrophage inflammation and heme oxygenase-1 expression, Biochem. Biophys. Res. Commun., 357, 319, 10.1016/j.bbrc.2007.03.150

Johnson, 2011, The effect of TOMM40 poly-T length on gray matter volume and cognition in middle-aged persons with APOE epsilon3/epsilon3 genotype, Alzheimers Dement., 7, 456, 10.1016/j.jalz.2010.11.012

Johnson, 2019, Apolipoprotein E4 mediates insulin resistance-associated cerebrovascular dysfunction and the post-prandial response, J. Cereb. Blood Flow Metab., 39, 770, 10.1177/0271678x17746186

Jones, 2019, Metabolic disturbances of a high-fat diet are dependent on APOE genotype and sex, eNeuro, 6, ENEURO.0267#x02013;19.2019, 10.1523/eneuro.0267-19.2019

Joo, 2018, Body mass index in mild cognitive impairment according to age, sex, cognitive intervention and hypertension and risk of progression to Alzheimer’s disease, Front. Psychiatry, 9, 142, 10.3389/fpsyt.2018.00142

Knopman, 2014, 18F-fluorodeoxyglucose positron emission tomography, aging and apolipoprotein E genotype in cognitively normal persons, Neurobiol. Aging, 35, 2096, 10.1016/j.neurobiolaging.2014.03.006

Konishi, 2018, Healthy versus entorhinal cortical atrophy identification in asymptomatic APOE4 carriers at risk for Alzheimer’s disease, J. Alzheimers Dis., 61, 1493, 10.3233/jad-170540

Krüger, 2009, Omega-3 fatty acids and risk of dementia: the Canadian study of health and aging, Am. J. Clin. Nutr., 90, 184, 10.3945/ajcn.2008.26987

Kulminski, 2019, Independent associations of TOMM40 and APOE variants with body mass index, Aging Cell, 18, e12869, 10.1111/acel.12869

Kulminski, 2020, APOE region molecular signatures of Alzheimer’s disease across races/ethnicities, Neurobiol. Aging, 87, 141.e1, 10.1016/j.neurobiolaging.2019.11.007

Laffitte, 2001, LXRs control lipid-inducible expression of the apolipoprotein E gene in macrophages and adipocytes, Proc. Natl. Acad. Sci. U S A, 98, 507, 10.1073/pnas.021488798

Laitinen, 2006, Fat intake at midlife and risk of dementia and Alzheimer’s disease: a population-based study, Dement. Geriatr. Cogn. Disord., 22, 99, 10.1159/000093478

Lee, 2012, Apolipoprotein E promotes β-amyloid trafficking and degradation by modulating microglial cholesterol levels, J. Biol. Chem., 287, 2032, 10.1074/jbc.M111.295451

Leonardini, 2009, Cross-talk between PPARγ and insulin signaling and modulation of insulin sensitivity, PPAR Res., 2009, 818945, 10.1155/2009/818945

Li, 2013, Molecular mechanisms responsible for the differential effects of apoE3 and apoE4 on plasma lipoprotein-cholesterol levels, Arterioscler. Thromb. Vasc. Biol., 33, 687, 10.1161/atvbaha.112.301193

Lucotte, 1997, Pattern of gradient of apolipoprotein E allele *4 frequencies in western Europe, Hum. Biol., 69, 253

Lyall, 2014, Are APOE varepsilon genotype and TOMM40 poly-T repeat length associations with cognitive ageing mediated by brain white matter tract integrity?, Transl. Psychiatry, 4, e449, 10.1038/tp.2014.89

Marmillot, 1999, Desialylation of human apolipoprotein E decreases its binding to human high-density lipoprotein and its ability to deliver esterified cholesterol to the liver, Metabolism, 48, 1184, 10.1016/s0026-0495(99)90136-1

Mastana, 1998, Anthropology of the apoplipoprotein E (apo E) gene: low frequency of apo E4 allele in Basques and in tribal (Baiga) populations of India, Ann. Hum. Biol., 25, 137, 10.1080/03014469800005512

Morris, 2016, Association of seafood consumption, brain mercury level and APOE epsilon4 status with brain neuropathology in older adults, JAMA, 315, 489, 10.1001/jama.2015.19451

Morrow, 2002, Apolipoprotein E4 forms a molten globule. A potential basis for its association with disease, J. Biol. Chem., 277, 50380, 10.1074/jbc.m204898200

Morrow, 2000, Differences in stability among the human apolipoprotein E isoforms determined by the amino-terminal domain, Biochemistry, 39, 11657, 10.1021/bi000099m

Mosconi, 2004, MCI conversion to dementia and the APOE genotype: a prediction study with FDG-PET, Neurology, 63, 2332, 10.1212/01.wnl.0000147469.18313.3b

Neu, 2017, Apolipoprotein E genotype and sex risk factors for Alzheimer disease: a meta-analysis, JAMA Neurol., 74, 1178, 10.1001/jamaneurol.2017.2188

Ngandu, 2015, A 2 year multidomain intervention of diet, exercise, cognitive training and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomised controlled trial, Lancet, 385, 2255, 10.1016/S0140-6736(15)60461-5

Nieminen, 2008, Pharmacogenetics of apolipoprotein E gene during lipid-lowering therapy: lipid levels and prevention of coronary heart disease, Pharmacogenomics, 9, 1475, 10.2217/14622416.9.10.1475

Nishimura, 2017, Characterization of APOE and TOMM40 allele frequencies in the Japanese population, Alzheimers Dement., 3, 524, 10.1016/j.trci.2017.07.003

Nixon, 2005, Endosome function and dysfunction in Alzheimer’s disease and other neurodegenerative diseases, Neurobiol. Aging, 26, 373, 10.1016/j.neurobiolaging.2004.09.018

Nuriel, , Neuronal hyperactivity due to loss of inhibitory tone in APOE4 mice lacking Alzheimer’s disease-like pathology, Nat. Commun., 8, 1464, 10.1038/s41467-017-01444-0

Nuriel, , The endosomal-lysosomal pathway is dysregulated by APOE4 expression in vivo, Front. Neurosci., 11, 702, 10.3389/fnins.2017.00702

O’Bryant, 2013, Characterization of Mexican Americans with mild cognitive impairment and Alzheimer’s disease, J. Alzheimers Dis., 33, 373, 10.3233/JAD-2012-121420

Oriá, 2010, ApoE polymorphisms and diarrheal outcomes in Brazilian shanty town children, Braz. J. Med. Biol. Res., 43, 249, 10.1590/s0100-879x2010007500003

Parikh, 2020, Murine gut microbiome association with APOE alleles, Front. Immunol., 11, 200, 10.3389/fimmu.2020.00200

Pelletier, 2015, Mediterranean diet and preserved brain structural connectivity in older subjects, Alzheimers Dement., 11, 1023, 10.1016/j.jalz.2015.06.1888

Peng, 2019, Apolipoprotein E4 genotype compromises brain exosome production, Brain, 142, 163, 10.1093/brain/awy289

Prasad, 2018, Amyloid clearance defect in ApoE4 astrocytes is reversed by epigenetic correction of endosomal pH, Proc. Natl. Acad. Sci. U S A, 115, E6640, 10.1073/pnas.1801612115

Price, 2006, Apolipoprotein epsilon3 allele is associated with persistent hepatitis C virus infection, Gut, 55, 715, 10.1136/gut.2005.079905

Quinn, 2010, Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: a randomized trial, JAMA, 304, 1903, 10.1001/jama.2010.1510

Raffai, 2001, Introduction of human apolipoprotein E4 “domain interaction” into mouse apolipoprotein E, Proc. Natl. Acad. Sci. U S A, 98, 11587, 10.1073/pnas.201279298

Rajabli, 2018, Ancestral origin of ApoE epsilon4 Alzheimer disease risk in Puerto Rican and African American populations, PLoS Genet., 14, e1007791, 10.1371/journal.pgen.1007791

Rajan, 2014, Gene-environment interaction of body mass index and apolipoprotein E ε4 allele on cognitive decline, Alzheimer Dis. Assoc. Disord., 28, 134, 10.1097/wad.0000000000000013

Rapp, 2017, Effect of a long-term intensive lifestyle intervention on cognitive function: action for health in diabetes study, J. Am. Geriatr. Soc., 65, 966, 10.1111/jgs.14692

Rawat, 2019, ApoE4 alters ABCA1 membrane trafficking in astrocytes, J. Neurosci., 39, 9611, 10.1523/jneurosci.1400-19.2019

Reger, 2004, Effects of β-hydroxybutyrate on cognition in memory-impaired adults, Neurobiol. Aging, 25, 311, 10.1016/S0197-4580(03)00087-3

Reiman, 2004, Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer’s dementia, Proc. Natl. Acad. Sci. U S A, 101, 284, 10.1073/pnas.2635903100

Risner, 2006, Efficacy of rosiglitazone in a genetically defined population with mild-to-moderate Alzheimer’s disease, Pharmacogenomics J., 6, 246, 10.1038/sj.tpj.6500369

Rönnemaa, 2012, Serum fatty-acid composition and the risk of Alzheimer’s disease: a longitudinal population-based study, Eur. J. Clin. Nutr., 66, 885, 10.1038/ejcn.2012.63

Roses, 2010, A TOMM40 variable-length polymorphism predicts the age of late-onset Alzheimer’s disease, Pharmacogenomics J., 10, 375, 10.1038/tpj.2009.69

Roses, 2014, African-American TOMM40’523-APOE haplotypes are admixture of West African and Caucasian alleles, Alzheimers Dement., 10, 592.e2, 10.1016/j.jalz.2014.06.009

Shaw, 2007, Cortical morphology in children and adolescents with different apolipoprotein E gene polymorphisms: an observational study, Lancet Neurol., 6, 494, 10.1016/s1474-4422(07)70106-0

Singh, 2006, APOE distribution in world populations with new data from India and the UK, Ann. Hum. Biol., 33, 279, 10.1080/03014460600594513

Solomon, 2018, Effect of the apolipoprotein e genotype on cognitive change during a multidomain lifestyle intervention: a subgroup analysis of a randomized clinical trial, JAMA Neurol., 75, 462, 10.1001/jamaneurol.2017.4365

Stonehouse, 2013, DHA supplementation improved both memory and reaction time in healthy young adults: a randomized controlled trial, Am. J. Clin. Nutr., 97, 1134, 10.3945/ajcn.112.053371

Sun, 2017, Hippocampal synaptic and neural network deficits in young mice carrying the human APOE4 gene, CNS Neurosci. Ther., 23, 748, 10.1111/cns.12720

Subramanian, 2017, The effects of PPARgamma on the regulation of the TOMM40-APOE-C1 genes cluster, Biochim. Biophys. Acta Mol. Basis Dis., 1863, 810, 10.1016/j.bbadis.2017.01.004

Tao, 2018, Association of chronic low-grade inflammation with risk of Alzheimer disease in ApoE4 carriers, JAMA Netw. Open, 1, e183597, 10.1001/jamanetworkopen.2018.3597

Tang, 1996, Relative risk of Alzheimer disease and age-at-onset distributions, based on APOE genotypes among elderly African Americans, Caucasians and Hispanics in New York City, Am. J. Hum. Genet., 58, 574

Tejedor, 2014, The apolipoprotein E polymorphism rs7412 associates with body fatness independently of plasma lipids in middle aged men, PLoS One, 9, e108605, 10.1371/journal.pone.0108605

Tensaouti, 2018, ApoE regulates the development of adult newborn hippocampal neurons, eNeuro, 5, ENEURO.0155–18.2018, 10.1523/eneuro.0155-18.2018

Theendakara, 2016, Direct transcriptional effects of apolipoprotein E, J. Neurosci., 36, 685, 10.1523/JNEUROSCI.3562-15.2016

Theendakara, 2017, Downregulation of protein phosphatase 2A by apolipoprotein E: Implications for Alzheimer’s disease, Mol. Cell. Neurosci., 83, 83, 10.1016/j.mcn.2017.07.002

Theendakara, 2018, Transcriptional effects of ApoE4: relevance to Alzheimer’s disease, Mol. Neurobiol., 55, 5243, 10.1007/s12035-017-0757-2

Tomaszewski, 2020, Effect of APOE genotype on plasma docosahexaenoic acid (DHA), eicosapentaenoic acid, arachidonic acid and hippocampal volume in the Alzheimer’s disease cooperative study-sponsored DHA clinical trial, J. Alzheimers Dis., 74, 975, 10.3233/jad-191017

Trumble, 2019, The exposome in human evolution: from dust to diesel, Q. Rev. Biol., 94, 333, 10.1086/706768

Trumble, 2017, Apolipoprotein E4 is associated with improved cognitive function in Amazonian forager-horticulturalists with a high parasite burden, FASEB J., 31, 1508, 10.1096/fj.201601084r

Tsivgoulis, 2013, Adherence to a Mediterranean diet and risk of incident cognitive impairment, Neurology, 80, 1684, 10.1212/wnl.0b013e3182904f69

Vamathevan, 2008, The role of positive selection in determining the molecular cause of species differences in disease, BMC Evol. Biol., 8, 273, 10.1186/1471-2148-8-273

van de Rest, 2008, Effect of fish oil on cognitive performance in older subjects A randomized, controlled trial, Neurology, 71, 430, 10.1212/01.wnl.0000324268.45138.86

van Exel, 2017, Effect of APOE epsilon4 allele on survival and fertility in an adverse environment, PLoS One, 12, e0179497, 10.1371/journal.pone.0179497

Vandal, 2014, Reduction in DHA transport to the brain of mice expressing human APOE4 compared to APOE2, J. Neurochem., 129, 516, 10.1111/jnc.12640

Venzi, 2017, Differential effect of APOE alleles on brain glucose metabolism in targeted replacement mice: an [18F]FDG-μPET study, J. Alzheimers Dis. Rep., 1, 169, 10.3233/adr-170006

Verghese, 2013, ApoE influences amyloid-β (Aβ) clearance despite minimal apoE/Aβ association in physiological conditions, Proc. Natl. Acad. Sci. U S A, 110, E1807, 10.1073/pnas.1220484110

Volcik, 2006, Apolipoprotein E polymorphisms predict low density lipoprotein cholesterol levels and carotid artery wall thickness but not incident coronary heart disease in 12,491 ARIC study participants, Am. J. Epidemiol., 164, 342, 10.1093/aje/kwj202

Weisgraber, 1990, Apolipoprotein E distribution among human plasma lipoproteins: role of the cysteine-arginine interchange at residue 112, J. Lipid Res., 31, 1503, 10.1016/S0022-2275(20)42621-5

Weisgraber, 1982, Abnormal lipoprotein receptor-binding activity of the human E apoprotein due to cysteine-arginine interchange at a single site, J. Biol. Chem., 257, 2518, 10.1016/S0021-9258(18)34954-8

Westerterp, 2013, Deficiency of ATP-binding cassette transporters A1 and G1 in macrophages increases inflammation and accelerates atherosclerosis in mice, Circ. Res., 112, 1456, 10.1161/circresaha.113.301086

Whalley, 2008, n-3 Fatty acid erythrocyte membrane content, APOE ε4, and cognitive variation: an observational follow-up study in late adulthood, Am. J. Clin. Nutr., 87, 449, 10.1093/ajcn/87.2.449

Williams, 2020, APOE alters glucose flux through central carbon pathways in astrocytes, Neurobiol. Dis., 136, 104742, 10.1016/j.nbd.2020.104742

Wolf, 2013, APOE and neuroenergetics: an emerging paradigm in Alzheimer’s disease, Neurobiol. Aging, 34, 1007, 10.1016/j.neurobiolaging.2012.10.011

Wolters, 2019, The impact of APOE genotype on survival: results of 38,537 participants from six population-based cohorts (E2-CHARGE), PLoS One, 14, e0219668, 10.1371/journal.pone.0219668

Wu, 2018, Human ApoE isoforms differentially modulate brain glucose and ketone body metabolism: implications for Alzheimer’s disease risk reduction and early intervention, J. Neurosci., 38, 6665, 10.1523/JNEUROSCI.2262-17.2018

Xu, 2016, Apolipoprotein E gene variants and risk of coronary heart disease: a meta-analysis, Biomed. Res. Int., 2016, 3912175, 10.1155/2016/3912175

Yassine, 2020, Do menopausal status and APOE4 genotype alter the long-term effects of intensive lifestyle intervention on cognitive function in women with type 2 diabetes mellitus?, Neurobiol. Aging, 92, 61, 10.1016/j.neurobiolaging.2020.03.020

Yassine, , Association of docosahexaenoic acid supplementation With Alzheimer disease stage in apolipoprotein E epsilon4 carriers: a review, JAMA Neurol., 74, 339, 10.1001/jamaneurol.2016.4899

Yassine, , DHA brain uptake and APOE4 status: a PET study with [1–11 C]-DHA, Alzheimers Res. Ther., 9, 23, 10.1186/s13195-017-0250-1

Yassine, , Association of serum docosahexaenoic acid with cerebral amyloidosis, JAMA Neurol., 73, 1208, 10.1001/jamaneurol.2016.1924

Yassine, , The effect of APOE genotype on the delivery of DHA to cerebrospinal fluid in Alzheimer’s disease, Alzheimers Res. Ther., 8, 25, 10.1186/s13195-016-0194-x

Yu, 2017, APOE epsilon4-TOMM40 ’523 haplotypes and the risk of Alzheimer’s disease in older Caucasian and African Americans, PLoS One, 12, e0180356, 10.1371/journal.pone.0180356

Yue, 2004, Divergent effects of peroxisome proliferator-activated receptor γ agonists and tumor necrosis factor α on adipocyte ApoE expression, J. Biol. Chem., 279, 47626, 10.1074/jbc.M408461200

Zade, 2013, Apolipoprotein epsilon 4 allele modifies waist-to-hip ratio effects on cognition and brain structure, J. Stroke Cerebrovasc. Dis., 22, 119, 10.1016/j.jstrokecerebrovasdis.2011.06.020

Zhao, 2017, Apolipoprotein E4 impairs neuronal insulin signaling by trapping insulin receptor in the endosomes, Neuron, 96, 115.e5, 10.1016/j.neuron.2017.09.003

Zhou, 2019, Non-coding variability at the APOE locus contributes to the Alzheimer’s risk, Nat. Commun., 10, 3310, 10.1038/s41467-019-10945-z

Zipser, 2007, Microvascular injury and blood-brain barrier leakage in Alzheimer’s disease, Neurobiol. Aging, 28, 977, 10.1016/j.neurobiolaging.2006.05.016